State Street Corp Onconova Therapeutics, Inc. Transaction History

State Street Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.57 - $1.0 $4,161 - $7,300	7,300 Added 13.83%	60,090 $35,000
Q2 2022 Aug 15, 2022	BUY	$1.04 - $1.9 $2,496 - $4,560	2,400 Added 4.76%	52,790 $70,000
Q3 2021 Nov 15, 2021	SELL	$3.81 - $6.76 $246,507 - $437,372	-64,700 Reduced 56.22%	50,390 $193,000
Q2 2021 Aug 16, 2021	BUY	$6.28 - $16.2 $722,765 - $1.86 Million	115,090 New	115,090 $798,000

276K

Ticker ONTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,895,600
Market Cap $12.3M
Description
Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.